Despite the Singaporean government's efforts to reduce screen time, it remains unlikely that overall screen exposure will decrease significantly in the near future. Eye care products are therefore poised to see sustained demand as consumers continue to face the challenges posed by prolonged screen usage.
Singapore has one of the highest myopia rates globally, affecting a significant portion of its population. Currently, products like Myopine, which are clinically developed to slow the progression of myopia, are available only by prescription.
In Singapore, an increasing consumer focus on overall wellbeing and preventative health is driving a notable shift toward eye health supplements. Indeed, eye health supplements, fortified with essential nutrients like lutein, zeaxanthin, and omega-3 fatty acids, is forecast to be one of the fastest growing segments within vitamins and dietary supplements in Singapore.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Eye Care industry in Singapore with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Eye Care industry in Singapore, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Eye Care
This category includes artificial tears, eye ointments, eye washes, and eye drops used to treat eye allergies, red eyes, or dry eyes. Excludes all products related to contact lens use and care.
See all of our definitionsThis report originates from Passport, our Eye Care research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!